Literature DB >> 22152852

The 2011 EBCTCG polychemotherapy overview.

Carlo Palmieri1, Alison Jones.   

Abstract

Mesh：

Year:  2011        PMID： 22152852     DOI： 10.1016/S0140-6736(11)61823-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Adjuvant Therapy Reduces Rate of Dissemination but Shortens Survival Thereafter.

Authors:  Michael K Fink; Ulrich R Kleeberg; Stefan Bartels
Journal:  Oncologist       Date:  2015-06-11

2.  In reply.

Authors:  Binghe Xu; Andrew Seidman; Stephen Chan
Journal:  Oncologist       Date:  2015-01

Review 3.  The optimal duration of adjuvant endocrine therapy for early stage breast cancer--with what drugs and for how long?

Authors:  Stephen R D Johnston; Belinda Yeo
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

4.  Trends in use and cost of initial cancer treatment in Ontario: a population-based descriptive study.

Authors:  Claire de Oliveira; Karen E Bremner; Reka Pataky; Nadia Gunraj; Mahbubul Haq; Kelvin Chan; Winson Y Cheung; Jeffrey S Hoch; Stuart Peacock; Murray D Krahn
Journal:  CMAJ Open       Date:  2013-12-09

5.  Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial.

Authors:  Olav Engebraaten; Hege Edvardsen; Erik Løkkevik; Bjørn Naume; Vessela Kristensen; Lars Ottestad; Vasanti Natarajan
Journal:  ISRN Oncol       Date:  2012-05-14

6.  Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer.

Authors:  W Si; Y Y Zhu; Y Li; P Gao; C Han; J H You; R X Linghu; S C Jiao; J L Yang
Journal:  Braz J Med Biol Res       Date:  2013-11-25       Impact factor: 2.590

7.  Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer.

Authors:  Si Sun; Lichen Tang; Jian Zhang; Fangfang Lv; Zhonghua Wang; Leiping Wang; Qunling Zhang; Chunlei Zheng; Lixin Qiu; Zhen Jia; Yunhua Lu; Guangyu Liu; Zhimin Shao; Biyun Wang; Xichun Hu
Journal:  Int J Nanomedicine       Date:  2014-03-19

8.  PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs.

Authors:  Beyhan Ataseven; Angela Gunesch; Wolfgang Eiermann; Ronald E Kates; Bernhard Högel; Pjotr Knyazev; Axel Ullrich; Nadia Harbeck
Journal:  Onco Targets Ther       Date:  2014-10-06       Impact factor: 4.147

Review 9.  Current treatment of early breast cancer: adjuvant and neoadjuvant therapy.

Authors:  Elizabeth Miller; Hee Jin Lee; Amriti Lulla; Liz Hernandez; Prashanth Gokare; Bora Lim
Journal:  F1000Res       Date:  2014-08-19

Review 10.  Taxane benefit in breast cancer--a role for grade and chromosomal stability.

Authors:  Roger P A'Hern; Mariam Jamal-Hanjani; A Marcell Szász; Stephen R D Johnston; Jorge S Reis-Filho; Rebecca Roylance; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2013-05-07       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.